STOCK TITAN

[Form 4] Astera Labs, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Astera Labs President and COO Sanjay Gajendra executed multiple stock sales on June 18, 2025, through a pre-planned Rule 10b5-1 trading arrangement established on November 30, 2024. The transactions included:

  • 52,933 shares sold at weighted average price of $98.3779
  • 4,926 shares sold at weighted average price of $99.2065
  • Two separate sales of 9,257 shares each at approximately $98.19 per share

Following these transactions, Gajendra's beneficial ownership stands at:

  • 2,262,318 shares held directly
  • 5,930,545 shares in Trust 1
  • 715,000 shares each in Trust 2 and Trust 3

The sales were executed automatically under the trading plan, demonstrating structured portfolio management by the insider. Gajendra maintains significant ownership through both direct holdings and trust arrangements, while disclaiming beneficial ownership of trust-held shares except for his pecuniary interest.

Sanjay Gajendra, Presidente e COO di Astera Labs, ha effettuato diverse vendite di azioni il 18 giugno 2025, tramite un piano di negoziazione predefinito conforme alla Regola 10b5-1, istituito il 30 novembre 2024. Le transazioni comprendevano:

  • 52.933 azioni vendute a un prezzo medio ponderato di 98,3779 $
  • 4.926 azioni vendute a un prezzo medio ponderato di 99,2065 $
  • Due vendite separate di 9.257 azioni ciascuna, a circa 98,19 $ per azione

Dopo queste operazioni, la proprietà effettiva di Gajendra è la seguente:

  • 2.262.318 azioni detenute direttamente
  • 5.930.545 azioni nel Trust 1
  • 715.000 azioni ciascuno nel Trust 2 e nel Trust 3

Le vendite sono state eseguite automaticamente secondo il piano di negoziazione, dimostrando una gestione strutturata del portafoglio da parte dell’insider. Gajendra mantiene una proprietà significativa sia tramite detenzioni dirette sia attraverso i trust, pur rinunciando alla proprietà effettiva delle azioni detenute nei trust, fatta eccezione per il suo interesse pecuniario.

Sanjay Gajendra, Presidente y COO de Astera Labs, realizó múltiples ventas de acciones el 18 de junio de 2025, mediante un plan de negociación preestablecido bajo la Regla 10b5-1, establecido el 30 de noviembre de 2024. Las transacciones incluyeron:

  • 52,933 acciones vendidas a un precio promedio ponderado de $98.3779
  • 4,926 acciones vendidas a un precio promedio ponderado de $99.2065
  • Dos ventas separadas de 9,257 acciones cada una a aproximadamente $98.19 por acción

Tras estas operaciones, la propiedad beneficiaria de Gajendra es:

  • 2,262,318 acciones en propiedad directa
  • 5,930,545 acciones en el Fideicomiso 1
  • 715,000 acciones cada una en el Fideicomiso 2 y el Fideicomiso 3

Las ventas se ejecutaron automáticamente bajo el plan de negociación, demostrando una gestión estructurada de la cartera por parte del insider. Gajendra mantiene una participación significativa tanto mediante tenencias directas como a través de fideicomisos, aunque renuncia a la propiedad beneficiaria de las acciones en fideicomisos salvo por su interés pecuniario.

Astera Labs의 사장 겸 COO인 Sanjay Gajendra는 2025년 6월 18일, 2024년 11월 30일에 설정된 사전 계획된 Rule 10b5-1 거래 계획을 통해 여러 차례 주식 매각을 실행했습니다. 거래 내역은 다음과 같습니다:

  • 가중 평균 가격 $98.3779에 52,933주 매각
  • 가중 평균 가격 $99.2065에 4,926주 매각
  • 약 $98.19에 각각 9,257주씩 두 차례 별도 매각

이 거래 후 Gajendra의 실질 소유 주식은 다음과 같습니다:

  • 직접 보유 주식 2,262,318주
  • 신탁 1에 5,930,545주
  • 신탁 2와 신탁 3에 각각 715,000주

이 매각은 거래 계획에 따라 자동으로 실행되었으며, 내부자의 체계적인 포트폴리오 관리를 보여줍니다. Gajendra는 직접 보유 및 신탁을 통해 상당한 소유권을 유지하면서, 신탁에 보유된 주식에 대한 실질 소유권은 금전적 이익을 제외하고는 부인하고 있습니다.

Sanjay Gajendra, Président et COO d'Astera Labs, a réalisé plusieurs ventes d’actions le 18 juin 2025, dans le cadre d’un plan de trading préétabli selon la règle 10b5-1, mis en place le 30 novembre 2024. Les transactions comprenaient :

  • 52 933 actions vendues à un prix moyen pondéré de 98,3779 $
  • 4 926 actions vendues à un prix moyen pondéré de 99,2065 $
  • Deux ventes distinctes de 9 257 actions chacune, à environ 98,19 $ par action

Après ces transactions, la détention effective de Gajendra est la suivante :

  • 2 262 318 actions détenues directement
  • 5 930 545 actions dans le Trust 1
  • 715 000 actions chacune dans le Trust 2 et le Trust 3

Ces ventes ont été exécutées automatiquement selon le plan de trading, illustrant une gestion structurée du portefeuille par l’initié. Gajendra conserve une participation significative à la fois par des détentions directes et via des trusts, tout en déclinant la propriété bénéficiaire des actions détenues dans les trusts, à l’exception de son intérêt pécuniaire.

Sanjay Gajendra, Präsident und COO von Astera Labs, führte am 18. Juni 2025 mehrere Aktienverkäufe durch, basierend auf einem vorab geplanten Handelsplan gemäß Regel 10b5-1, der am 30. November 2024 eingerichtet wurde. Die Transaktionen umfassten:

  • 52.933 Aktien zu einem gewichteten Durchschnittspreis von 98,3779 $ verkauft
  • 4.926 Aktien zu einem gewichteten Durchschnittspreis von 99,2065 $ verkauft
  • Zwei separate Verkäufe von jeweils 9.257 Aktien zu etwa 98,19 $ pro Aktie

Nach diesen Transaktionen hält Gajendra folgende wirtschaftliche Eigentumsanteile:

  • 2.262.318 Aktien direkt gehalten
  • 5.930.545 Aktien im Trust 1
  • 715.000 Aktien jeweils im Trust 2 und Trust 3

Die Verkäufe wurden automatisch gemäß dem Handelsplan ausgeführt und zeigen ein strukturiertes Portfoliomanagement durch den Insider. Gajendra behält bedeutende Eigentumsanteile sowohl durch direkte Beteiligungen als auch durch Trusts, während er das wirtschaftliche Eigentum an den im Trust gehaltenen Aktien mit Ausnahme seines finanziellen Interesses ablehnt.

Positive
  • None.
Negative
  • None.

Sanjay Gajendra, Presidente e COO di Astera Labs, ha effettuato diverse vendite di azioni il 18 giugno 2025, tramite un piano di negoziazione predefinito conforme alla Regola 10b5-1, istituito il 30 novembre 2024. Le transazioni comprendevano:

  • 52.933 azioni vendute a un prezzo medio ponderato di 98,3779 $
  • 4.926 azioni vendute a un prezzo medio ponderato di 99,2065 $
  • Due vendite separate di 9.257 azioni ciascuna, a circa 98,19 $ per azione

Dopo queste operazioni, la proprietà effettiva di Gajendra è la seguente:

  • 2.262.318 azioni detenute direttamente
  • 5.930.545 azioni nel Trust 1
  • 715.000 azioni ciascuno nel Trust 2 e nel Trust 3

Le vendite sono state eseguite automaticamente secondo il piano di negoziazione, dimostrando una gestione strutturata del portafoglio da parte dell’insider. Gajendra mantiene una proprietà significativa sia tramite detenzioni dirette sia attraverso i trust, pur rinunciando alla proprietà effettiva delle azioni detenute nei trust, fatta eccezione per il suo interesse pecuniario.

Sanjay Gajendra, Presidente y COO de Astera Labs, realizó múltiples ventas de acciones el 18 de junio de 2025, mediante un plan de negociación preestablecido bajo la Regla 10b5-1, establecido el 30 de noviembre de 2024. Las transacciones incluyeron:

  • 52,933 acciones vendidas a un precio promedio ponderado de $98.3779
  • 4,926 acciones vendidas a un precio promedio ponderado de $99.2065
  • Dos ventas separadas de 9,257 acciones cada una a aproximadamente $98.19 por acción

Tras estas operaciones, la propiedad beneficiaria de Gajendra es:

  • 2,262,318 acciones en propiedad directa
  • 5,930,545 acciones en el Fideicomiso 1
  • 715,000 acciones cada una en el Fideicomiso 2 y el Fideicomiso 3

Las ventas se ejecutaron automáticamente bajo el plan de negociación, demostrando una gestión estructurada de la cartera por parte del insider. Gajendra mantiene una participación significativa tanto mediante tenencias directas como a través de fideicomisos, aunque renuncia a la propiedad beneficiaria de las acciones en fideicomisos salvo por su interés pecuniario.

Astera Labs의 사장 겸 COO인 Sanjay Gajendra는 2025년 6월 18일, 2024년 11월 30일에 설정된 사전 계획된 Rule 10b5-1 거래 계획을 통해 여러 차례 주식 매각을 실행했습니다. 거래 내역은 다음과 같습니다:

  • 가중 평균 가격 $98.3779에 52,933주 매각
  • 가중 평균 가격 $99.2065에 4,926주 매각
  • 약 $98.19에 각각 9,257주씩 두 차례 별도 매각

이 거래 후 Gajendra의 실질 소유 주식은 다음과 같습니다:

  • 직접 보유 주식 2,262,318주
  • 신탁 1에 5,930,545주
  • 신탁 2와 신탁 3에 각각 715,000주

이 매각은 거래 계획에 따라 자동으로 실행되었으며, 내부자의 체계적인 포트폴리오 관리를 보여줍니다. Gajendra는 직접 보유 및 신탁을 통해 상당한 소유권을 유지하면서, 신탁에 보유된 주식에 대한 실질 소유권은 금전적 이익을 제외하고는 부인하고 있습니다.

Sanjay Gajendra, Président et COO d'Astera Labs, a réalisé plusieurs ventes d’actions le 18 juin 2025, dans le cadre d’un plan de trading préétabli selon la règle 10b5-1, mis en place le 30 novembre 2024. Les transactions comprenaient :

  • 52 933 actions vendues à un prix moyen pondéré de 98,3779 $
  • 4 926 actions vendues à un prix moyen pondéré de 99,2065 $
  • Deux ventes distinctes de 9 257 actions chacune, à environ 98,19 $ par action

Après ces transactions, la détention effective de Gajendra est la suivante :

  • 2 262 318 actions détenues directement
  • 5 930 545 actions dans le Trust 1
  • 715 000 actions chacune dans le Trust 2 et le Trust 3

Ces ventes ont été exécutées automatiquement selon le plan de trading, illustrant une gestion structurée du portefeuille par l’initié. Gajendra conserve une participation significative à la fois par des détentions directes et via des trusts, tout en déclinant la propriété bénéficiaire des actions détenues dans les trusts, à l’exception de son intérêt pécuniaire.

Sanjay Gajendra, Präsident und COO von Astera Labs, führte am 18. Juni 2025 mehrere Aktienverkäufe durch, basierend auf einem vorab geplanten Handelsplan gemäß Regel 10b5-1, der am 30. November 2024 eingerichtet wurde. Die Transaktionen umfassten:

  • 52.933 Aktien zu einem gewichteten Durchschnittspreis von 98,3779 $ verkauft
  • 4.926 Aktien zu einem gewichteten Durchschnittspreis von 99,2065 $ verkauft
  • Zwei separate Verkäufe von jeweils 9.257 Aktien zu etwa 98,19 $ pro Aktie

Nach diesen Transaktionen hält Gajendra folgende wirtschaftliche Eigentumsanteile:

  • 2.262.318 Aktien direkt gehalten
  • 5.930.545 Aktien im Trust 1
  • 715.000 Aktien jeweils im Trust 2 und Trust 3

Die Verkäufe wurden automatisch gemäß dem Handelsplan ausgeführt und zeigen ein strukturiertes Portfoliomanagement durch den Insider. Gajendra behält bedeutende Eigentumsanteile sowohl durch direkte Beteiligungen als auch durch Trusts, während er das wirtschaftliche Eigentum an den im Trust gehaltenen Aktien mit Ausnahme seines finanziellen Interesses ablehnt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gajendra Sanjay

(Last) (First) (Middle)
C/O ASTERA LABS, INC.
2345 NORTH FIRST STREET

(Street)
SAN JOSE CA 95131

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Astera Labs, Inc. [ ALAB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and COO
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/18/2025 S(1) 52,933 D $98.3779(2) 5,935,471 I By Trust 1(3)
Common Stock 06/18/2025 S(1) 4,926 D $99.2065(4) 5,930,545 I By Trust 1(3)
Common Stock 06/18/2025 S(1) 9,257 D $98.1927(5) 715,000 I By Trust 2(6)
Common Stock 06/18/2025 S(1) 9,257 D $98.1968(5) 715,000 I By Trust 3(7)
Common Stock 2,262,318 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 30, 2024.
2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.1000 to $99.0900, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. These shares are owned directly by an estate planning trust ("Trust 1"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.1100 to $99.3300, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.1000 to $98.3500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
7. These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Remarks:
/s/ Philip Mazzara, Attorney-in-Fact 06/23/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many ALAB shares did President and COO Sanjay Gajendra sell on June 18, 2025?

Sanjay Gajendra sold a total of 76,373 shares on June 18, 2025, consisting of 52,933 shares at an average price of $98.3779, 4,926 shares at $99.2065, and two blocks of 9,257 shares each at prices around $98.19.

What was the price range of ALAB stock sales by Sanjay Gajendra in the June 18, 2025 transactions?

The ALAB stock sales occurred at various price points: the largest block was sold at prices ranging from $98.10 to $99.09, another block at $99.11 to $99.33, and two additional blocks at prices ranging from $98.10 to $98.35.

How many ALAB shares does Sanjay Gajendra still own directly after the June 2025 sales?

After the reported transactions, Sanjay Gajendra directly owns 2,262,318 shares of ALAB stock. Additionally, he has indirect ownership through three trust arrangements totaling approximately 7.36 million shares.

Was Sanjay Gajendra's ALAB stock sale part of a planned transaction?

Yes, the sales were executed automatically pursuant to a Rule 10b5-1 trading plan that was adopted by Gajendra on November 30, 2024. This type of plan is commonly used by insiders to avoid allegations of insider trading by scheduling trades in advance.

What positions does Sanjay Gajendra hold at ALAB according to the Form 4?

According to the Form 4, Sanjay Gajendra serves as both a Director and President and COO (Chief Operating Officer) of Astera Labs, Inc. (ALAB).
ASTERA LABS INC

NASDAQ:ALAB

ALAB Rankings

ALAB Latest News

ALAB Latest SEC Filings

ALAB Stock Data

14.17B
142.64M
15.86%
69.18%
5.89%
Semiconductors
Semiconductors & Related Devices
Link
United States
SANTA CLARA